01.01.2017

First clinical study findings published in Anesthesiology

Anesthesiology, the prestigious journal of the American Society of Anesthesiologists, has published our first findings in an article titled .
The study conducted in collaboration with the Oulu University Hospital tested the possibility of using propofol-induced slow-wave activity as an early predictor of neurologic outcome after cardiac arrest. As the editors of the journal point out, no reliable methods currently exist for assessing brain function in the early stages of recovery from hypoxic, ischemic, or traumatic insults that might inform neurologic prognosis and therapy.
In the study of comatose cardiac arrest survivors, propofol-induced slow-wave activity was present in a greater proportion of patients with good neurologic outcome than in those with poor outcome. The promising finding of the study is expected to lead to the development of a pharmacologic test for the prognostication of brain injury.
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
OULU
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
FINLAND
HELSINKI
Cerenion Oy
Firdonkatu 2 T 63
00520 Helsinki
FINLAND
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2021 Cerenion Oy